Recent News

• 08.14.2025 - Phio Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
• 07.25.2025 - Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

Recent Filings

• 08.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.04.2025 - D Notice of Exempt Offering of Securities
• 07.30.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 07.30.2025 - DEF 14A Other definitive proxy statements
• 07.30.2025 - 8-K Current report
• 07.30.2025 - ARS Annual Report to Security Holders
• 07.30.2025 - EX-99.1 EX-99.1
• 07.25.2025 - 8-K Current report
• 07.25.2025 - EX-99.1 EX-99.1
• 07.07.2025 - 8-K Current report